Medical Weight Loss services
medical weight loss
The definition of medical weight loss is weight loss that is achieved under the guidance and supervision of a licensed healthcare provider, such as a physician, physician assistant, or nurse practitioner. Nurses may also provide this service, but only under the direct supervision and prescribed guidance of a licensed medical provider.
Did you know?
Cardiovascular disease remains the number on killer in America?
By reducing 5% of you body mass, you can drastically reduce your overall cardiovascular disease risk.
Tirzepatide and Semaglutide have some differences. Let’s discuss which one is right for you.
Things to remember …
Everyone’s individual reasons and goals for starting a medical weight loss journey are unique.
Obesity is an independent risk factor for the development of cardiovascular disease. Which remains the #1 cause of death in America. Nearly 73% of Americans 2o years of age and older are overweight.
Slow and steady wins the race. Plan to follow a minimum of a 12 week program before considering maintenance therapy.
Peer-reviewed medical journals have published data that supports the safety of long-term use of Tirzepatide as maintenance therapy in weight management.
If you have a personal, or family, history of certain tumors, such as Multiple Endocine Neoplasia, Semaglutide (Ozempic® Wegovy®) and Tirzepatide (Mounjaro®) are not recommended therapies. A responsible healthcare provider will screen you for this.
Hypertension
According to the CDC, nearly 1 in 2 adults in America have high blood pressure, and only 1 in 4 have their blood pressure under control. Hypertension accounts for approximately 500,000 deaths per year in the United States.
Not only does medical weight weight loss from Tirzepatide and Semaglutide have an impressive impact on blood pressure control, it also lowers triglycerides and bad cholesterol, while increases good cholesterol. It also reduces inflammatory markers, and major cardiac events.
wEIGHT LOSS tIPS
ESSENTIAL POINTS:
Losing 20 pounds has been shown to reduce LDL (the bad cholesterol) by 15%
Losing 5% of body weight reduces your overall risk of developing cardiovascular disease
Belly fat is a well established individual risk factor, associated with increased risk of overall death.
Drink plenty of water. It is very common for those on Semaglutide and Tirzepatide to forget to drink enough water. Very often, nausea associated with these therapies is due to dehydration
Don’t forget to communicate any concerns with your healthcare provider
Medical weight loss and improved cardiovascular health is enhanced by healthy food choices and regular exercise.